The ivWatch team is returning to the Society of Critical Care Medicine’s (SCCM) Critical Care Congress on February 25-27, 2018 for the third consecutive year. The Society’s Congress embarks on their 47th annual event and remains the largest critical care event bringing together members of the multi-professional, multidisciplinary critical care field.
ivWatch representatives will be at booth 224 in the exhibit hall educating attendees about the latest technology advancements in peripheral IV therapy care. ivWatch shares in the Society’s mission of securing the highest quality care for all critically ill and injured patients.
In previous years, we’ve met with several pediatric and neonatal intensive care unit teams as well as those in the operating room. Whether you are a department or patient safety director, sit on a value-analysis committee, or simply interested in learning about evidence-based ways to improve patient care, we invite you to stop by or reach out. We’ll have ongoing demonstrations of the ivWatch Model 400, the only medical device and biosensor technology that continuously monitors the IV site for the early detection of IV infiltrations to help improve patient safety and minimize patient harm.
We look forward to collaborating with critical care experts and internationally renowned faculty in a few weeks.
HAMPTON, Va.., February 6, 2018 – ivWatch, LLC has been awarded a group purchasing agreement as a Breakthrough Technology with Premier. Effective Feb.1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the ivWatch Model 400, a continuous monitoring device for the early detection of peripheral IV (PIV) infiltrations.
“We are thrilled to be recognized by Premier as a Breakthrough Technology which accelerates the standard GPO process and enables us to educate more organizations about our technology offering a new standard of care for PIVs,” said Scott Hensley, vice president of sales and business development at ivWatch. “This recognition is a testament to the need for a technology solution in hospitals for continuous IV monitoring for early detection of IV infiltrations and extravasations.”
This relationship enables Premier members to implement continuous monitoring of a patient’s PIV for evidence of infiltrations to improve patient outcomes. Intravenous therapy is a routine part of treatment for nearly 80 percent of patients in the U.S., yet more than 20 percent of these IVs may fail due to infiltration, risking both a serious drug delivery error and tissue damage. The ivWatch sensor technology is a solution to aid the clinician in early detection of this most serious event.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 3,900 U.S. hospitals and 150,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLC. https://www.ivwatch.com/
ivWatch President and CEO Discusses Thoughts on Human Factors and Technology Acceptance in Healthcare
ivWatch’s Gary Warren penned an exclusive piece for MedTech Intelligence titled, “.” In the column, he discusses how medical device human factor engineering must account for all groups within the Diffusion of Innovation curve. MedTech Intelligence is an industry-specific website that aids in the advancement and progress of the global medical device and diagnostic industry.
Read his column here.
ivWatch Chief Nursing Officer on WTKR’s Coast Live
ivWatch’s Susan Brown educated viewers about patient empowerment and IV care and risks. The morning show segment included information about how the ivWatch device detects IV infiltrations early and ways current and future hospital patients can prepare for this common but often overlooked procedure.
View the full segment here.
First website of its kind provides information and tips on ‘all things IV, simplified’ to inform and empower patients and their family members to be their own healthcare advocates
Hampton, VA – January 23, 2018 – Today marks the start of the #myIVawareness campaign with the official launch of myIV.com, a new resource to empower and inform patients and family members responsible for care on intravenous (IV) therapy. myIV.com, sponsored by ivWatch, is the first online patient resource of its kind providing visitors simplified information about IVs and the symptoms of possible complications.
Nearly 80 percent of all hospital patients receive an IV1, making it the most common invasive medical procedure. Still, close to 50 percent of IVs fail due to complications. Every failure of an IV results in a drug delivery error and carries the potential for reduced drug efficacy and physical harm. Complications range from skin redness, burning, tissue necrosis, limb amputation and even death.
“To have a single location with reliable and relevant information on IVs is filling a large gap in patient education,” said Susan Brown, MSN, RN, Med, VA–BC. “I spent many years educating patients and their families on what an IV was, why it was needed and complication symptoms. To have a site for patients to reference before and during a hospital stay will help facilitate better conversations with healthcare professionals.”
Users of the site have free access to comprehensive educational content including a guide on how to talk to your healthcare professional, definitions of common medical terms, IV FAQs, as well as patient stories.
Caitlin King, myIV.com’s first “Patient Spotlight,” wishes she had access to an IV awareness website when one of her twin daughters experienced IV issues shortly after being born seven weeks premature. King hopes other parents take from her experience the importance of educating themselves when it comes to children and IVs.
“There is no awareness about IVs, it’s not talked about, and yet it happens every day,” said King. “As a parent, helplessness is one of the worst feelings in the world. If there is something you can do when it comes to knowing what to look for, do it.”
To learn more about myIV.com and #myIVawareness, visit www.myIV.com and follow myIV.com on Facebook, Twitter, LinkedIn and Pinterest.
1. Zhang, L., Cao, S., Marsh, N., Ray-Barruel, G., Flynn, J., Larsen, E. and Rickard, C.M. (2016) Infection risks associated with peripheral vascular catheters. Journal of Infection Prevention. 17(5), p.207-213. doi: 10.1177/1757177416655472
myIV.com is an online patient resource portal dedicated to empowering patients with information related to receiving an IV. As the first website of its kind focused on IVs and IV therapy, myIV.com fills the gap in patient education and makes IVs easier to understand. myIV.com is sponsored by ivWatch. Help raise #myIVawareness on Twitter, Facebook, LinkedIn and Pinterest. For more information, visit www.myIV.com.
MEDIA CONTACT: Amara Betoney, firstname.lastname@example.org, Office (757) 224-2606, Mobile (757) 660-4949
ivWatch included in Extremetech.com’s CES healthcare coverage
ivWatch was included in a recent round-up article of the stand-out healthcare devices on display at CES 2018. The ivWatch device was praised as an innovation to enable disruption in the healthcare industry and empower consumers to monitor and manage their health and wellness. The article discusses the problem, symptoms and frequency of IV infiltration events and the application of ivWatch technology to improve patient care.
Read the full article here.